Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke

Pharmacological Reports

Volumn 62, Issue 4, 2010, Pages 751-756

  Lagowska Lenard, Monika ^a   Stelmasiak, Zbigniew ^a   Bartosik Psujek, Halina ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antioxidants; Ischemic stroke; Oxidative stress

Indexed keywords

ASCORBIC ACID; BILIRUBIN; CREATININE; URIC ACID;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; OXIDATIVE STRESS; TREATMENT DURATION; URIC ACID BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 77958013479     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70334-0     Document Type: Article

References (24)

1. Aygul R, Kotan D, Demirbas F, Ulvi H, Deniz O: Plasma oxidants and antioxidants in acute ischaemic stroke. J Int Med Res, 2006, 34, 413-418.
2. Castillo J, Dávalos A, Noya M: Progression of ischaemic stroke and excitotoxic aminoacids. Lancet, 1997, 349, 79-83.
3. Clark JE, Foresti R, Green CJ, Motterlini R: Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J, 2000, 348, 615-619.
4. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy; a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev, 2001, 53, 135-159.
5. Dohi K, Mochizuki Y, Satoh K, Jimbo H, Hayashi M, Toyoda I., Ikeda Y et al.: Transient elevation of serum bilirubin (a heme oxygenase-1 metabolite) level in hemorrhagic stroke: bilirubin is a marker of oxidant stress. Acta Neurochir Suppl, 2003, 86, 247-249.
6. Herishanu Y, Abramsky O, Lavy S: Hyperbilirubinaemia in acute ischaemic stroke. J Neurol Sci, 1971, 14, 417-420.
7. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, Gossios T et al.: Serum uric acid as an independent predictor of early death after acute stroke. Circ J, 2007, 71, 1120-1127.
8. Leinonen JS, Ahonen JP, Lönnorot K, Jehkonen M, Dastidar P, Molnár G, Alho H: Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke, 2000, 31, 33-39.
9. Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw K-T: Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer-Norfolk prospective population study. Am J Clin Nutr, 2008, 87, 64-69.
10. Ness AR, Powles JW, Khaw KT: Vitamin C and cardiovascular disease: a systematic review. J Cardiovasc Risc, 1996, 3, 513-521.
11. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Meccoci P: Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res, 2002, 36, 265-268.
12. Polidori MC, Frei B, Cherubini A, Nelles G, Rordorf G, Keaney JF Jr, Schwamm L et al.: Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med, 1998, 25, 561-567.
13. Polidori MC., Practicó D, Ingegni T, Mariani E, Spazzafumo L, del Sindaco P, Cecchetti R et al.: Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study. Biofactors, 2005, 24, 265-274.
14. Rabadi MH, Kristal BS: Effect of vitamin C supplementation on stroke recovery: a case-control study. Clin Interv Aging, 2007, 2, 147-151
15. Sanchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A: Decreased levels of plasma vitamin C and increased concentration of inflammatory and oxidative stress markers after stroke. Stroke, 2004, 35, 163-168.
16. Sanchez-Moreno C, Jimenez-Escrig A, Martin A: Stroke: roles of B vitamins, homocysteine and antioxidants. Nutr Res Rev, 2009, 22, 49-67.
17. Squadito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA: Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys, 2000, 376, 333-337.
18. Spranger M, Krempien S, Schwab S, Donneberg S, Hacke W: Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke, 1997, 28, 2425-2428.
19. Sridharan R: Risk factors for ischemic stroke: a case control analysis. Neuroepidemiology, 1992, 11, 24-30.
20. Ullegaddi R, Powers HJ, Gariballa SE: Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr, 2005, 59, 1367-1373.
21. Ullegaddi R, Powers HJ, Gariballa SE: Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial. JPEN J Parenter Enteral Nutr, 2006, 30, 108-114.
22. Weir CJ, Muir SW, Walters MR, Lees KR: Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke, 2003, 34, 1951-1956.
23. Yokoyama T, Date C, Kokubo Y, Yoshiike N, Matsumura Y, Tanaka H: Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community. The Shibata study. Stroke, 2000, 31, 2287-2294.
24. Zimmermann C, Winnefeld K, Streck S, Roskos M, Haberl RL: Antioxidant status in acute stroke patients and patients of stroke risk. Eur Neurol, 2004, 51, 157-161.